Combretastatin A1 Diphosphate

The diphosphate prodrug of the stilbenoid combretastatin A1, originally isolated from the plant Combretum caffrum, with vascular-disrupting and antineoplastic activities. Upon administration, combretastatin A1 diphosphate (CA1P) is dephosphorylated to the active metabolite combretastatin A1 (CA1), which promotes rapid microtubule depolymerization; endothelial cell mitotic arrest and apoptosis, destruction of the tumor vasculature, disruption of tumor blood flow and tumor cell necrosis may ensue. In addition, orthoquinone intermediates, metabolized from combretastatin A1 by oxidative enzymes found to be elevated in some tumor types, may bind to tumor cell thiol-specific antioxidant proteins and DNA, and stimulate oxidative stress by enhancing superoxide/hydrogen peroxide production. CA1 binds to tubulin at the same site as colchicine but with higher affinity. (NCI Thesaurus)

YOU MAY ALSO LIKE

Combretastatin A-4

An inhibitor of microtubule polymerization derived from the South African willow bush which causes mitotic arrest and selectively targets and reduces or…

Combretastatin

A stilbenoid phenol, originally isolated from the bark of the African bush willow tree Combretum caffrum, with vascular disrupting and antineoplastic…

Combined Thymic Epithelial Neoplasm

A primary thymic epithelial neoplasm, characterized by the presence of at least two distinct areas, one representing a thymoma and the other…

Combined Small Cell Lung Carcinoma and Lung Adenocarcinoma

A lung carcinoma characterized by a combination of small cell carcinoma and adenocarcinoma.

Combined Small Cell Lung Carcinoma

A morphologic variant of small cell lung carcinoma in combination with a non-small cell carcinoma.

Combined Small Cell and Squamous Cell Lung Carcinoma

A lung carcinoma characterized by a combination of small cell carcinoma and squamous cell carcinoma.